Breo Ellipta
- Product NDC
- 50090-2404
- 11-digit product format
- 500902404
- Labeler code
- 50090
- Product ID
- 50090-2404_5b5dae35-bf7b-48f9-9e04-fa83ce96c135
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fluticasone furoate and vilanterol trifenatate
- Dosage form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- Labeler
- A-S Medication Solutions
- Application
- NDA204275
- Marketing category
- NDA
- Marketing start
- 2015-04-30
- Marketing end
- 0000-00-00
- Substance
- FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
- Active strength
- 200 ug/1; ug/1
- Pharmacologic classes
- Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#